Literature DB >> 19755046

NCCN Clinical Practice Guidelines in Oncology: colon cancer.

Paul F Engstrom1, Juan Pablo Arnoletti, Al B Benson, Yi-Jen Chen, Michael A Choti, Harry S Cooper, Anne Covey, Raza A Dilawari, Dayna S Early, Peter C Enzinger, Marwan G Fakih, James Fleshman, Charles Fuchs, Jean L Grem, Krystyna Kiel, James A Knol, Lucille A Leong, Edward Lin, Mary F Mulcahy, Sujata Rao, David P Ryan, Leonard Saltz, David Shibata, John M Skibber, Constantinos Sofocleous, James Thomas, Alan P Venook, Christopher Willett.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19755046     DOI： 10.6004/jnccn.2009.0056

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  193 in total

Review 1.  Challenges in the management of older patients with colon cancer.

Authors:  Efrat Dotan; Ilene Browner; Arti Hurria; Crystal Denlinger
Journal:  J Natl Compr Canc Netw       Date:  2012-02       Impact factor: 11.908

2.  Targeted therapies in colorectal cancer: surgical considerations.

Authors:  Carrie Luu; Amanda K Arrington; Hans F Schoellhammer; Gagandeep Singh; Joseph Kim
Journal:  J Gastrointest Oncol       Date:  2013-09

3.  Measuring concordance with guidelines for the diagnosis and treatment of colon cancer.

Authors:  R Rahal; J Klein-Geltink; T Forte; G Lockwood; H Bryant
Journal:  Curr Oncol       Date:  2013-08       Impact factor: 3.677

4.  Positive peritoneal washing cytology is a potential risk factor for the recurrence of curatively resected colorectal cancer.

Authors:  Yoichiro Homma; Takashi Hamano; Yasuhiro Akazawa; Yoshiro Otsuki; Shinichi Shimizu; Hiroshi Kobayashi; Shingo Kameoka; Yasuyuki Kobayashi
Journal:  Surg Today       Date:  2013-08-14       Impact factor: 2.549

5.  Proposal of a new classification for stage III colorectal cancer based on the number and ratio of metastatic lymph nodes.

Authors:  Li-Ping Wang; Hong-Yan Wang; Rui Cao; Cong Zhu; Xiong-Zhi Wu
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352

6.  Influence of primary tumor resection on survival in asymptomatic patients with incurable stage IV colorectal cancer.

Authors:  Akira Watanabe; Kentaro Yamazaki; Yusuke Kinugasa; Shunsuke Tsukamoto; Tomohiro Yamaguchi; Akio Shiomi; Takahiro Tsushima; Tomoya Yokota; Akiko Todaka; Nozomu Machida; Akira Fukutomi; Yusuke Onozawa; Hirofumi Yasui
Journal:  Int J Clin Oncol       Date:  2014-02-15       Impact factor: 3.402

7.  An open-label study of the safety and tolerability of pazopanib in combination with FOLFOX6 or CapeOx in patients with colorectal cancer.

Authors:  Joanne Brady; Pippa Corrie; Ian Chau; Raghunadharao Digumarti; Laurel M Adams; Jeffrey Botbyl; Kevin H Laubscher; Rachel S Midgley; Mohandas Mallath
Journal:  Invest New Drugs       Date:  2013-02-28       Impact factor: 3.850

8.  Treatment results of FOLFOX chemotherapy before surgery for lymph node metastasis of advanced colorectal cancer with synchronous liver metastasis: the status of LN metastasis and vessel invasions at the primary site in patients who responded to FOLFOX.

Authors:  Hiroshi Sawayama; Naoko Hayashi; Shinobu Honda; Yoshifumi Baba; Eiichirou Toyama; Masayuki Watanabe; Hiroshi Takamori; Toru Beppu; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2010-01-21       Impact factor: 3.402

9.  KRAS mutation analysis on low percentage of colon cancer cells: the importance of quality assurance.

Authors:  J R Dijkstra; D A M Heideman; G A Meijer; J E Boers; N A 't Hart; J Diebold; A Hirschmann; G Hoefler; G Winter; G Miltenberger-Miltenyi; S V Pereira; S D Richman; P Quirke; E L Rouleau; J M Guinebretiere; S Tejpar; B Biesmans; J H J M van Krieken
Journal:  Virchows Arch       Date:  2012-12-15       Impact factor: 4.064

Review 10.  KRAS mutation testing in metastatic colorectal cancer.

Authors:  Cong Tan; Xiang Du
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.